Nolato Q1 2019: Continued strong performance from Medical Solutions
Nolato AB has today published its interim report for the first three months of 2019. · Sales totalled SEK 1,656 million (2,039) · Operating profit (EBITA) amounted to SEK 175 million (SEK 264 million incl. non-recurring items of SEK 20 million) · EBITA margin of 10.6% (12.0% excl. non-recurring items) · Profit after tax was SEK 131 million (206) · Basic earnings per share totalled SEK 4.98 (7.83) · Cash flow after investments amounted to SEK 25 million (187) · Sustained strong financial position Medical Solutions sales rose to SEK 611 million (532). Adjusted for